Skip to main content
Journal cover image

Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.

Publication ,  Journal Article
Davitz, MS; Wu, WE; Soher, BJ; Babb, JS; Kirov, II; Huang, J; Fatterpekar, G; Gonen, O
Published in: Magn Reson Imaging
January 2017

BACKGROUND AND PURPOSE: To assess the sensitivity of non-localized, whole-head 1H-MRS to an individual's serial changes in total-brain NAA, Glx, Cr and Cho concentrations - metabolite metrics often used as surrogate markers in neurological pathologies. MATERIALS AND METHODS: In this prospective study, four back-to-back (single imaging session) and three serial (successive sessions) non-localizing, ~3min 1H-MRS (TE/TR/TI=5/104/940ms) scans were performed on 18 healthy young volunteers: 9 women, 9 men: 29.9±7.6 [mean±standard deviation (SD)] years old. These were analyzed by calculating a within-subject coefficient of variation (CV=SD/mean) to assess intra- and inter-scan repeatability and prediction intervals. This study was Health Insurance Portability and Accountability Act compliant. All subjects gave institutional review board-approved written, informed consent. RESULTS: The intra-scan CVs for the NAA, Glx, Cr and Cho were: 3.9±1.8%, 7.3±4.6%, 4.0±3.4% and 2.5±1.6%, and the corresponding inter-scan (longitudinal) values were: 7.0±3.1%, 10.6±5.6%, 7.6±3.5% and 7.0±3.9%. This method is shown to have 80% power to detect changes of 14%, 27%, 26% and 19% between two serial measurements in a given individual. CONCLUSIONS: Subject to the assumption that in neurological disorders NAA, Glx, Cr and Cho changes represent brain-only pathology and not muscles, bone marrow, adipose tissue or epithelial cells, this approach enables us to quantify them, thereby adding specificity to the assessment of the total disease load. This will facilitate monitoring diffuse pathologies with faster measurement, more extensive (~90% of the brain) spatial coverage and sensitivity than localized 1H-MRS.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Magn Reson Imaging

DOI

EISSN

1873-5894

Publication Date

January 2017

Volume

35

Start / End Page

15 / 19

Location

Netherlands

Related Subject Headings

  • Young Adult
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Reference Values
  • Proton Magnetic Resonance Spectroscopy
  • Prospective Studies
  • Nuclear Medicine & Medical Imaging
  • Male
  • Humans
  • Glutamine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Davitz, M. S., Wu, W. E., Soher, B. J., Babb, J. S., Kirov, I. I., Huang, J., … Gonen, O. (2017). Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T. Magn Reson Imaging, 35, 15–19. https://doi.org/10.1016/j.mri.2016.08.012
Davitz, Matthew S., William E. Wu, Brian J. Soher, James S. Babb, Ivan I. Kirov, Jeffrey Huang, Girish Fatterpekar, and Oded Gonen. “Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.Magn Reson Imaging 35 (January 2017): 15–19. https://doi.org/10.1016/j.mri.2016.08.012.
Davitz MS, Wu WE, Soher BJ, Babb JS, Kirov II, Huang J, et al. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T. Magn Reson Imaging. 2017 Jan;35:15–9.
Davitz, Matthew S., et al. “Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.Magn Reson Imaging, vol. 35, Jan. 2017, pp. 15–19. Pubmed, doi:10.1016/j.mri.2016.08.012.
Davitz MS, Wu WE, Soher BJ, Babb JS, Kirov II, Huang J, Fatterpekar G, Gonen O. Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T. Magn Reson Imaging. 2017 Jan;35:15–19.
Journal cover image

Published In

Magn Reson Imaging

DOI

EISSN

1873-5894

Publication Date

January 2017

Volume

35

Start / End Page

15 / 19

Location

Netherlands

Related Subject Headings

  • Young Adult
  • Sensitivity and Specificity
  • Reproducibility of Results
  • Reference Values
  • Proton Magnetic Resonance Spectroscopy
  • Prospective Studies
  • Nuclear Medicine & Medical Imaging
  • Male
  • Humans
  • Glutamine